Array Biopharma Inc financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2014-12-31 3 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31 3 months ending 2013-12-31
Revenue 26.92 6.07 6.01 7.77 14.07
Other Revenue, Total - - - - -
Total Revenue 26.92 6.07 6.01 7.77 14.07
Cost of Revenue, Total 13.10 12.18 11.44 10.76 13.11
Gross Profit 13.82 -6.11 -5.43 -2.98 0.96
Selling/General/Admin. Expenses, Total 8.08 6.80 5.85 5.41 5.47
Research & Development 11.82 12.19 14.50 14.13 9.49
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - 0.00 - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 32.99 31.17 31.79 30.29 28.07
Operating Income -6.07 -25.10 -25.78 -22.52 -14.00
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -8.61 -27.59 -28.24 -24.93 -16.41
Income After Tax -8.61 -27.59 -28.24 -24.93 -16.41
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -8.61 -27.59 -28.24 -24.93 -16.41
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -8.61 -27.59 -28.24 -24.93 -16.41
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -8.61 -27.59 -28.24 -24.93 -16.41
Income Available to Common Incl. Extra Items -8.61 -27.59 -28.24 -24.93 -16.41
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 0.00 0.00 0.00 0.00
Diluted Weighted Average Shares 133.81 131.83 126.78 125.47 123.92
Diluted EPS Excluding Extraordinary Items -0.06 -0.21 -0.22 -0.20 -0.13
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 - 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.06 -0.21 -0.22 -0.20 -0.13